Log in
30.06.2025

Deal of the Week |

Calendar Week # 26 |

2025

Zama Logo

Zama Raises $57M In Series B To Bring End-to-End Encryption To Public Blockchains

  • HQ: CH

Founded: 2020

  • Series B
  • Sector: Blockchain

Investment Raised: USD 57m €

USD 1.1b

Valuation

Investors: Blockchange Ventures, GSR, Julien Bouteloup, Pantera Capital

News Link
30.06.2025

Deal |

2025

Swiss startup Boost inc secures €16 million to accelerate international growth in unattended retail

  • HQ: CH

Founded: 2020

  • Series B
  • Sector: Consumer Goods

Investment Raised: CHF 16m €

Valuation Remains Undisclosed

Investors: Capmont Technology, Direttissima Growth Partners, kineo finance

News Link
02.06.2025

Deal of the Week |

Calendar Week # 22 |

2025

GlycoEra raises USD 130 Million Series B to advance targeted autoimmune therapies

  • HQ: CH

Founded: 2020

  • Series B
  • Sector: Biotechnology

Investment Raised: USD 130m €

Valuation Remains Undisclosed

Investors: 5AM Ventures, Agent Capital, Bristol-Myers Squibb, Catalio Capital Management, LifeArc Ventures, MP Healthcare Venture Management, Novo Holdings, Qatar Investment Authority, Roche Venture Fund, Sixty Degree Capital, Sofinnova Partners

News Link
22.05.2025

Deal |

2025

Jeito Capital Leads a USD 65 million Financing in ReproNovo to Develop Transformational Treatments in Reproductive Medicine and Women’s Health

  • HQ: CH

Founded: 2021

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 65m €

Valuation Remains Undisclosed

Investors: ALSA Ventures, AXA Investment Managers, Jeito Capital, M Ventures, Ysios Capital

News Link
09.05.2025

Deal |

2025

Amazon’s Bezos leads $72m investment in AI data firm Toloka

  • HQ: CH

Founded: 2014

  • Venture – Series Unknown
  • Sector: Analytics Artificial Intelligence Ai

Investment Raised: USD 72m €

Valuation Remains Undisclosed

Investors: Bezos Expeditions, Mikhail Parakhin

News Link
09.05.2025

Deal |

2025

HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases

  • HQ: CH

Founded: 2017

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 65m €

Valuation Remains Undisclosed

Investors: +ND Capital, 4See Ventures, Alexandria Venture Investments, Apollo Health Ventures, ATHOS, Bernina BioInvest, Earlybird Venture Capital, Eli Lilly, LifeLink Ventures, Longview Ventures, Schroders Capital, Sofinnova Partners

News Link
27.03.2025

Deal |

2025

Carlyle provides €250m strategic capital for Sanoptis

  • HQ: CH

Founded: 2018

  • Private Equity
  • Sector: Health Care

Investment Raised: EUR 250m €

Valuation Remains Undisclosed

Investors: The Carlyle Group

News Link
14.03.2025

Deal |

2025

Beekeeper secures $35 million growth funding

  • HQ: CH

Founded: 2012

  • Venture – Series Unknown
  • Sector: Enterprise Software

Investment Raised: USD 35m €

Valuation Remains Undisclosed

Investors: HSBC Innovation Banking

News Link
27.02.2025

Deal |

2025

Sparta Secures $42M Series B led by One Peak to Transform Commodity Trading with AI-Powered Insights and Collaboration

  • HQ: CH

Founded: 2020

  • Series B
  • Sector: Oil And Gas

Investment Raised: USD 42m €

Valuation Remains Undisclosed

Investors: FirstMark, One Peak, Singular

News Link
19.02.2025

Deal |

2025

Hospitality revenue management provider RoomPriceGenie receives $75M for expansion

  • HQ: CH

Founded: 2017

  • Venture – Series Unknown
  • Sector: Software

Investment Raised: USD 75m €

Valuation Remains Undisclosed

Investors: Five Elms Capital

News Link
05.02.2025

Deal |

2025

Oxyle secures USD 16M to permanently remove PFAS from water

  • HQ: CH

Founded: 2020

  • Seed
  • Sector: Environmental Consulting

Investment Raised: USD 16m €

Valuation Remains Undisclosed

Investors: 360 Capital, Axeleo Capital, Founderful, SOSV

News Link
15.01.2025

Deal |

2025

Swiss crypto-focused bank Sygnum hits unicorn status after raising €56.54M strategic growth round

  • HQ: CH

Founded: 2017

  • Venture – Series Unknown
  • Sector: FinTech

Investment Raised: USD 58m €

Valuation Remains Undisclosed

Investors: Fulgur Ventures

News Link
13.01.2025

Deal |

2025

Inrate Announces Successful Capital Raise to Accelerate Growth and Innovation

  • HQ: CH

Founded: 1990

  • Funding Round
  • Sector: Financial Services

Investment Raised: CHF 5m €

Valuation Remains Undisclosed

News Link
13.01.2025

Deal of the Week |

Calendar Week # 2 |

2025

CeQur secures $120 million to scale diabetes management solutions

  • HQ: CH

Founded: 2008

  • Venture – Series Unknown
  • Sector: Health Care

Investment Raised: USD 120m €

Valuation Remains Undisclosed

News Link
10.01.2025

Deal |

Calendar Week # 2 |

2025

CeQur secures $120 million to scale diabetes management solutions

  • HQ: CH

Founded: 2008

  • Venture – Series Unknown
  • Sector: Health Care

Investment Raised: USD 120m €

Valuation Remains Undisclosed

News Link
10.01.2025

Deal |

2025

Numab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing

  • HQ: CH

Founded: 2011

  • Series C
  • Sector: Biotechnology

Investment Raised: CHF 50m €

Valuation Remains Undisclosed

Investors: BlackRock, BVF Partners, Cormorant Asset Management, Forbion Capital Partners, HBM Healthcare Investments, Novo Holdings, Octagon Capital Advisors, RTW Investments

News Link
13.11.2024

Deal |

2024

LocalStack raises $25M to help developers emulate and test cloud apps locally

  • HQ: CH

Founded: 2021

  • Series A
  • Sector: Information Technology

Investment Raised: USD 25m €

Valuation Remains Undisclosed

Investors: CRV, Heavybit, Notable Capital

News Link
13.11.2024

Deal |

2024

Novo Holdings, OrbiMed, Jeito lead $181M fundraise for ADC biotech

  • HQ: CH

Founded: 2019

  • Series D
  • Sector: Biotechnology

Investment Raised: USD 181.4m €

Valuation Remains Undisclosed

Investors: Avego Bioscience Capital, Bpifrance, Catalio Capital Management, Frazier Life Sciences, Jeito Capital, Longitude Capital, Morningside Venture Investments, Novo Holdings, OrbiMed, Piper Heartland Healthcare Capital, Pureos Bioventures, RA Capital Management

News Link
23.10.2024

Deal of the Week |

Calendar Week # 43 |

2024

terralayr secures €77M to build AWS of grid-scale battery storage

  • HQ: CH

Founded: 2022

  • Venture – Series Unknown
  • Sector: Renewable Energy

Investment Raised: EUR 77m €

Valuation Remains Undisclosed

Investors: Creandum, Earlybird Venture Capital, Norrsken VC, Picus Capital, Rive Private Investment

News Link
20.09.2024

Deal |

2024

Neo Medical Secures Landmark Equity Investment of $68 million to Accelerate Global Growth in Spine Surgery

  • HQ: CH

Founded: 2013

  • Series B
  • Sector: Health Care

Investment Raised: CHF 58m €

Valuation Remains Undisclosed

Investors: Gyrus Capital, Jonas Larsson, Vincent Lefauconnier

News Link
13.09.2024

Deal |

2024

CorFlow Therapeutics AG Completes €44 Million Series B Financing

  • HQ: CH

Founded: 2016

  • Series B
  • Sector: Medical Device

Investment Raised: EUR 44m €

Valuation Remains Undisclosed

Investors: 415 Capital, Broadview Ventures, KOFA Healthcare Investments, Laerdal Million Lives Fund, M&L Healthcare Investments, Monte Carlo Capital, Mérieux Equity Partners, Panakes Partners, Unorthodox Ventures, Wellington Partners

News Link
29.08.2024

Deal of the Week |

Calendar Week # 35 |

2024

Amazon and Bezos Expeditions to Back Robot-Maker Swiss-Mile

  • HQ: CH

Founded: 2023

  • Seed
  • Sector: Artificial Intelligence (AI), Information Technology, Manufacturing, Robotics

Investment Raised: USD 20M €

USD 78M

Valuation

Investors: Linear Capital, HongShan, Bezos Expeditions, Armada Investment AG, Amazon Industrial Innovation Fund

News Link
24.07.2024

Deal |

2024

H55 Keeping Up the Momentum: Series C Funding Closed, Accelerating Electric Propulsion Certification

  • HQ: CH

Founded: 2015

  • Series C
  • Sector: Aerospace, Electronics, Manufacturing

Investment Raised: CHF 65M €

Valuation Remains Undisclosed

Investors: Government Of Quebec

News Link
21.06.2024

Deal of the Week |

Calendar Week # 25 |

2024

iOnctura Raises EUR80M in Series B Financing

  • HQ: CH

Founded: 2017

  • Series B
  • Sector: Biotechnology

Investment Raised: EUR 80M €

Valuation Remains Undisclosed

Investors: VI Partners, Syncona Partners LLP, Schroders Capital, M Ventures, Inkef, European Innovation Council, 38 Future Health Fund

News Link
01.04.2024

Deal of the Month |

April |

2024

Neurosterix launches with $63M to Advance Allosteric Modulator Therapeutics for Neurological Disorders

  • HQ: CH

Founded: 2024

  • Series A

Investment Raised: USD 63M €

Valuation Remains Undisclosed

Investors: Perceptive Life Sciences Perceptive Advisors Acorn Bioventures

News Link
01.04.2024

Deal of the Week |

Calendar Week # 14 |

2024

Neurosterix launches with $63M to Advance Allosteric Modulator Therapeutics for Neurological Disorders

  • HQ: CH

Founded: 2024

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 63M €

Valuation Remains Undisclosed

Investors: Perceptive Life Sciences Perceptive Advisors Acorn Bioventures

News Link
25.03.2024

Deal |

2024

Volumina Medical secures USD 21 million

  • HQ: CH

Founded: 2017

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 21M €

Valuation Remains Undisclosed

Investors: undefined

News Link
25.03.2024

Deal |

2024

CHF 14 million to fund Hemotune’s clinical trials

  • HQ: CH

Founded: 2016

  • Series B
  • Sector: Biotechnology

Investment Raised: CHF 14M €

Valuation Remains Undisclosed

Investors: Belmondo (https://belmondo.io/) EFI Lake Geneva Ventures (https://lakegenevaventures.com/) Hemex (https://hemex.ch/) OCCIDENT (https://www.occident.group/) VP Venture Partners (https://www.vpventurepartners.com/) Zurcher Kantonal Bank (https://www.zkb.ch/)

News Link
21.03.2024

Deal |

2024

Angelini Ventures invests into extended €75.8 million Series C financing round for Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized cancer vaccines

  • HQ: CH

Founded: 2015

  • Series C
  • Sector: Biotechnology

Investment Raised: EUR 75.8M €

Valuation Remains Undisclosed

Investors: 5AM Ventures (https://5amventures.com/) Andera Partners (https://www.anderapartners.com/en/) Angelini Ventures (https://www.angeliniventures.com/) Bpifrance (https://www.bpifrance.com/) EQT life science (https://eqtgroup.com/private-capital/life-sciences/) Indaco Venture Partners (https://www.indacosgr.com/) M Ventures (https://www.m-ventures.com/) Panakes Partners (https://www.panakes.it/) Revelation Partners (https://revelation-partners.com/) Versant Ventures (https://www.versantventures.com/) XGEN Venture (https://xgenventure.com/)

News Link
18.03.2024

Deal of the Week |

Calendar Week # 12 |

2024

Angelini Ventures invests into extended €75.8 million ($82 million) Series C financing round for Nouscom

  • HQ: CH

Founded: 2015

  • Series C
  • Sector: Biotechnology

Investment Raised: EUR 75.8M €

Valuation Remains Undisclosed

Investors: 5AM Ventures Andera Partners Angelini Ventures Bpifrance EQT life science Indaco Venture Partners M Ventures Panakes Partners Revelation Partners Versant Ventures XGEN Venture

News Link